Agilon Health Q3 EPS $(0.27) Misses $(0.16) Estimate, Sales $1.435B Beat $1.423B Estimate

Agilon Health (NYSE:AGL) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.16) by 70.89 percent. This is a 6.9 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $1.435 billion which beat the analyst consensus estimate of $1.423 billion by 0.82 percent. This is a 1.10 percent decrease over sales of $1.451 billion the same period last year.